Stem Cell :: US President Bush disappointed in House Vote on Embryonic Stem Cell Bill
US President Bush disappointed in House Vote on Embryonic Stem Cell Bill. The following is a statement by US President Bush:
US President Bush disappointed in House Vote on Embryonic Stem Cell Bill. The following is a statement by US President Bush:
GlaxoSmithKline plc [LSE and NYSE: GSK] announced long-term efficacy data from a Phase II trial of a single one-week course of frontline treatment with the BEXXAR? Therapeutic Regimen (Tositumomab and Iodine I-131 Tositumomab) in 76 patients with newly diagnosed advanced follicular non-Hodgkin?s lymphoma (NHL).
Researchers at the Institute for Stem Cell Biology and Medicine at UCLA were able to take normal tissue cells and reprogram them into cells with the same unlimited properties as embryonic stem cells, the cells that are able to give rise to every cell type found in the body.
Embryonic stem cells are unique because they can develop into virtually any kind of tissue type, an attribute called pluripotency. Somatic cell nuclear transfer (?therapeutic cloning?) offers the hope of one day creating customized embryonic stem cells with a patient?s own DNA. Here, an individual?s DNA would be placed into an egg, resulting in a blastocyst that houses a supply of stem cells. But to access these cells, researchers must destroy a viable embryo.
News that scientists have derived cells that behave like stem cells from the skin of a mouse is a major scientific breakthrough that underscores the need to continue human embryonic stem cell research, The Foundation for Taxpayer and Consumer Rights (FTCR) said.
Dozens of patients and their families joined Senate Majority Leader Harry Reid, Speaker Nancy Pelosi and Members of Congress today as they enrolled a bill that offers real hope to millions of Americans suffering from debilitating diseases and conditions by greatly expanding scientists? access to embryonic stem cell lines.
The Stanford University School of Medicine has received $4.1 million to renovate laboratory areas for human embryonic stem cell research and to provide a stem cell training course through the latest round of funding from the California Institute for Regenerative Medicine.
Researchers at the Abramson Family Cancer Research Institute of the University of Pennsylvania have found that deleting a gene important in embryo development leads to premature aging and loss of stem cell reservoirs in adult mice.
As stem cells in the blood grow older, genetic mutations accumulate that could be at the root of blood diseases that strike people as they age, according to work done in mice by researchers at the Stanford University School of Medicine.
Researchers at the Institute for Stem Cell Biology and Medicine at UCLA were able to take normal tissue cells and reprogram them into cells with the same unlimited properties as embryonic stem cells, the cells that are able to give rise to every cell type found in the body.